Viravaxx

Viravaxx presents poster at AASLD

Vienna, Nov 15, 2021. Petra Steindl-Munda, principal investigator of Viravaxx’ ongoing VVX001 clinical study, presents interim-data today in a virtual poster session at AASLD (American Association for the Study of Liver Diseases). The poster is entitled: “Vaccination with the preS-based grass pollen allergy vaccine VVX001 enhances HBV virus-specific immunity in vivo”. Click here to view | read more ยป

Vienna, Nov 15, 2021. Petra Steindl-Munda, principal investigator of Viravaxx’ ongoing VVX001 clinical study, presents interim-data today in a virtual poster session at AASLD (American Association for the Study of Liver Diseases). The poster is entitled: “Vaccination with the preS-based grass pollen allergy vaccine VVX001 enhances HBV virus-specific immunity in vivo”. Click here to view poster.